Microvessel density and endothelial cell proliferation after amifostine (Ethyol®) administration in vivo

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 4241-4245

  Plasswilm, L ^a   Hanjalic, A ^b   Hoeper, J ^b   Cordes, N ^b   Tannapfel, A ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NONE

Author keywords

Amifostine; Angiogenesis; In vivo

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; ALKALINE PHOSPHATASE; AMIFOSTINE; CYCLINE; RADIOPROTECTIVE AGENT; SODIUM CHLORIDE;

ARTICLE; CAPILLARY DENSITY; CELL PROLIFERATION; CHICK EMBRYO; CONTROLLED STUDY; DRUG EFFICACY; DRUG METABOLISM; EMBRYO; ENDOTHELIUM CELL; HISTOMETRY; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; ZYGOTE;

EID: 0032778496     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Patt HM, Tyree EB, Straube RL, Smith DE: Cysteine protection against X irradiation. Science 110: 213-214, 1949.
2. Davidson DE, Grenan MM, Sweeney TR: Biological characteristics of some improved radioprotectors. Radiation sensitizers: Their use in clinical management of cancer. In: Brady LW ed. New York, NY, Masson, 309 1980.
3. Smoluk GD, Fahey RC, Calabro-Jones PM: Radioprotection of cells in culture by WR-2721 and derivates: Form of the drug responsible for protection. Cancer Res 48: 3641-3647, 1988.
4. Kemp G, Rose P, Lurain J, Berman M, Manetta A, Roullet B, Homesley H, Belpomme D, Glick J: Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicity's: Results of a randomized control trial in patients with advanced ovarian cancer. J Clin Oncol 14: 2101-2112, 1996.
5. Liu T, Liu Y, He S: Use of radiation with or with out WR-2721 in advanced rectal cancer. Cancer 69: 2820-2825, 1992.
6. McDonald S, Meyerowitz C, Smudzin T, Rubin P: Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck produce salivary gland dysfunction. Int J Radiat Oncol Biol Phys 29: 747-754, 1994.
7. Treskes M, Boven E, Loosdrecht AA: Effects of the modulating agent WR-2721 on myelotoxicity and antitumor activity in carboplatin-treated mice. E J C 30: 183-187, 1994.
8. Yuhas JM: Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2[3-aminopropylamino]ethyl-phosphorothioic acid. Cancer Res 40: 1519-1524, 1980.
9. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
10. Leon SP, Folkerth RD, Black PM: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77: 362-372, 1996.
11. Höper J, Jahn H: Influence of environmental oxygen concentration on growth and vascular density of the area vasculosa in chick embryos. Int J Microcirc 15: 186-192, 1995.
12. Plasswilm L, Höper J: In vivo investigation of vascular density and local mitochondrial metabolism after irradiation. Adv Exp Med Biol 428: 115-122, 1997.
13. Crum R, Szaho S, Folkman J: A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230: 1375-1378, 1985.
14. Rosenbruch M: Toxizitätsuntersuchungen am bebrüteten Hühnerei. Unter besonderer Berücksichtigung der extraembryonalen Gefäßsysteme. Dermatosen 38: 5-11, 1990.
15. Glazier JB, Hughes JMB, Maloney JE, West JB: Vertical gradient of alveolar size in lungs of dogs frozen intact. J Appl Physiol 23: 694-705, 1967.
16. Tannapfel A, Hahn H, Katalinic A, Fietkau R, Kühn R, Wittekind Ch: Prognostic value of proliferation markers in renal cell carcinoma. Cancer 77: 164-171, 1996.
17. Quinn CM, Wright NA: The clinical assessment of proliferation and growth in human tumors: evaluation of methods and application as prognostic variables. J Pathol 160: 93-102, 1990.
18. Yang JL, Fernandes DJ, Speicher L: Biochemical determinants of the cytoprotective effect of amifostine. Proc Am Assoc Cancer Res 36: 290 (abstr 1725), 1995.
19. Shaw LM, Bonner HS, Turrisi A, Norfleet AL, Glover DJ: A liquid chromatographic electrochemical assay for S-2[3-aminopropylamino]ethylphophorothioate (WR-2721) in human plasma. J Liq Chromatog 7: 2447-2465, 1984.
20. Romanul FCA, Bannister RG: Localized areas of high alkaline phosphatase activity in endothelium of arteries. Nature 195: 611-612, 1962.
21. 35S-labeled 3-amino-2-hydroxypropyl phosphorothiate (WR-77913). Radiat Res 102: 130-137, 1985.
22. Alexander P, Bacq ZM, Cousens SF, Fox M, Herve A, Lazar J: Mode of action of some substances which protect against the lethal effect of x-rays. Radiat Res 2: 392-415, 1955.
23. Shigematsu N, Schwartz JL, Grdina DJ: Protection against radiation-induced mutagenesis at the hprt locus by spermine and N,N″ (dithiodi-2, 1-ethanediyl) bis-1, 3-propanediamine (WR-33278). Mutagenesis 9: 355, 1994.
24. Treskes M, Boven E, Holwerdea U: Time dependence of selective modulation of cisplatin-induced nephrotoxicity by WR-2721 in the mouse. Cancer Res 52: 2257-2260, 1992.
25. Speicher LA, Krutzsh M, Wymer J, Alberts DS, Capizzi RL: Amifostine does not inhibit the cytotoxic effect of a broad range of standard anticancer drugs against human ovarian and breast cancer cells. Proc Am Assoc Cancer Res 36: 290 (abstract 1727), 1995.
26. Paine G, Taylor CW, Lopez MHA: Effects of amifostine and paclitaxel on growth of human ovarian carcinoma in xenografts in the severe combined immune deficient mouse: preliminary results. Sem Oncol 23 (Suppl 8): 35-39, 1996.
27. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase-_. Nature 326: 515-517, 1987.
28. Celis JE, Celis A: Cell cycle dependent variations in the distribution of the nuclear protein cyclin proliferating nuclear antigen in cultuerd cells: subdivision of S phase. Proc Natl Acad Sci USA 82: 3262-3266, 1985
29. Iatropoulos MJ, Williams GM: Proliferation markers. Exp Toxicol Pathol 48: 175-181, 1996.
30. Sanders EJ, Varedi M, French AS: Cell proliferation in the gastrulating chick embryo: a study using BrdU incorporation and PCNA localization. Development 118: 389-399, 1993.